Wordt geladen...
The rational design of affinity-attenuated OmCI for the purification of complement C5
Complement component C5 is the target of the mAb eculizumab and is the focus of a sustained drug discovery effort to prevent complement-induced inflammation in a range of autoimmune diseases. The immune evasion protein OmCI binds to and potently inactivates C5; this tight-binding interaction can be...
Bewaard in:
| Gepubliceerd in: | J Biol Chem |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Biochemistry and Molecular Biology
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6130949/ https://ncbi.nlm.nih.gov/pubmed/30030376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA118.004043 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|